Ondine Biomedical Inc on Wednesday said that the research it presented at a conference in San Francisco proves the efficacy of its Steriwave nasal photo disinfection system.

According to the Vancouver-based life sciences company, the system significantly reduces pathogens in the nose but does not produce long-term adverse effects on the nasal microbiome.

The research, which was presented at the SPIE Photonics West conference in San Francisco, demonstrated an immediate and highly significant reduction in viable bacterial cells and number of species, sustained for at least 24 hours.

‘These findings support Steriwave as an efficient, potent, short-acting, and non-selective method of nasal decolonization, with the advantage of rapid recovery of the native microbiome post-treatment,’ Ondine commented.

Ondine Biomedical shares were trading 1.3% lower at 10.11 pence each in London on Wednesday afternoon.

Copyright 2024 Alliance News Ltd. All Rights Reserved.